136 related articles for article (PubMed ID: 22390206)
1. Comparison of adherence between twice- and thrice-daily regimens of oral amoxicillin/clavulanic acid.
Llor C; Bayona C; Hernández S; Moragas A; Miravitlles M
Respirology; 2012 May; 17(4):687-92. PubMed ID: 22390206
[TBL] [Abstract][Full Text] [Related]
2. The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance.
Llor C; Sierra N; Hernández S; Moragas A; Hernández M; Bayona C; Miravitlles M
J Antimicrob Chemother; 2009 Feb; 63(2):396-9. PubMed ID: 19015142
[TBL] [Abstract][Full Text] [Related]
3. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
4. [Compliance rate of antibiotic therapy in patients with acute pharyngitis is very low, mainly when thrice-daily antibiotics are given].
Llor C; Sierra N; Hernández S; Bayona C; Hernández M; Moragas A; Calviño O
Rev Esp Quimioter; 2009 Mar; 22(1):20-4. PubMed ID: 19308742
[TBL] [Abstract][Full Text] [Related]
5. A study of adherence to antibiotic treatment in ambulatory respiratory infections.
Llor C; Hernández S; Bayona C; Moragas A; Sierra N; Hernández M; Miravitlles M
Int J Infect Dis; 2013 Mar; 17(3):e168-72. PubMed ID: 23116609
[TBL] [Abstract][Full Text] [Related]
6. Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial.
Kardas P
J Antimicrob Chemother; 2007 Mar; 59(3):531-6. PubMed ID: 17289766
[TBL] [Abstract][Full Text] [Related]
7. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial.
Clegg HW; Ryan AG; Dallas SD; Kaplan EL; Johnson DR; Norton HJ; Roddey OF; Martin ES; Swetenburg RL; Koonce EW; Felkner MM; Giftos PM
Pediatr Infect Dis J; 2006 Sep; 25(9):761-7. PubMed ID: 16940830
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.
Odenholt I; Cars O; Löwdin E
J Antimicrob Chemother; 2004 Dec; 54(6):1062-6. PubMed ID: 15563517
[TBL] [Abstract][Full Text] [Related]
9. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
[TBL] [Abstract][Full Text] [Related]
10. Association between use of rapid antigen detection tests and adherence to antibiotics in suspected streptococcal pharyngitis.
Llor C; Hernández S; Sierra N; Moragas A; Hernández M; Bayona C
Scand J Prim Health Care; 2010 Mar; 28(1):12-7. PubMed ID: 20201628
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial.
Vilas-Boas AL; Fontoura MS; Xavier-Souza G; Araújo-Neto CA; Andrade SC; Brim RV; Noblat L; Barral A; Cardoso MR; Nascimento-Carvalho CM;
J Antimicrob Chemother; 2014 Jul; 69(7):1954-9. PubMed ID: 24648506
[TBL] [Abstract][Full Text] [Related]
12. Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care.
Cals JW; Hopstaken RM; Le Doux PH; Driessen GA; Nelemans PJ; Dinant GJ
Int J Antimicrob Agents; 2008 Jun; 31(6):531-6. PubMed ID: 18457936
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains.
Anon JB; Ferguson B; Twynholm M; Wynne B; Berkowitz E; Poole MD
Ear Nose Throat J; 2006 Aug; 85(8):500, 502, 504 passim. PubMed ID: 16999056
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
García Callejo FJ; Velert Vila MM; Orts Alborch MH; Pardo Mateu L; Esparcia Navarro M
Acta Otorrinolaringol Esp; 1998 May; 49(4):306-12. PubMed ID: 9707742
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections.
Stegemann MR; Coati N; Passmore CA; Sherington J
J Small Anim Pract; 2007 Jul; 48(7):378-86. PubMed ID: 17559523
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
19. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis.
Lennon DR; Farrell E; Martin DR; Stewart JM
Arch Dis Child; 2008 Jun; 93(6):474-8. PubMed ID: 18337284
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections.
Shanks N; Macklin J; Coles S
Clin Ther; 1989; 11(6):812-9. PubMed ID: 2692823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
